Skip to main content
Equibles

MORGAN STANLEY

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,454,725
+$3,078,174 QoQ
Shares Held
629,035
+6.7% QoQ
Ownership
0.977%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CGEM ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,454,725 629,035
2026-03-31 $8,376,551 589,483
2025-12-31 $7,937,762 766,934
2025-09-30 $2,372,910 400,154
2025-06-30 $1,822,950 242,092
2025-03-31 $3,647,464 481,832
2024-12-31 $7,771,676 638,069
2024-09-30 $11,272,245 673,372
2024-06-30 $14,619,653 838,283
2024-03-31 $19,641,051 1,152,644
2023-12-31 $9,373,766 919,899
2023-09-30 $2,564,911 283,416
2023-06-30 $3,497,933 325,087
2023-03-31 $1,697,643 165,948
2022-12-31 $2,373,936 225,018
2022-09-30 $3,695,745 288,280
2022-06-30 $4,429,857 345,543
2022-03-31 $5,212,747 497,875
2021-12-31 $5,083,502 329,456
2021-09-30 $1,597,931 70,799
2021-06-30 $1,708,485 66,349
2021-03-31 $16,042 385